; or (B) an organization described in section 501(c)(3) of the Internal Revenue Code of 1986 and exempt from tax under section 501(a) of such Code. (2) The entity has experienced personnel, and clinical and other technical expertise, in the biomedical sciences. (3) The entity demonstrates to the Secretary’s satisfaction that the entity is capable of carrying out the activities described in subsection (a)(2). (c) Annual report Not later than 18 months after the date of enactment of this section, and annually thereafter, the Secretary, in collaboration with the grantees under this section, shall submit a report to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives— (1) reviewing the operations and activities of the Pediatric Research Site Network in the previous year; and (2) addressing such other issues relating to this section as the Secretary determines to be appropriate. (d) Definition In this section, the term medical product means a drug (including a biological product), a device (including a diagnostic test), and any combination product described in section 503(g). (e) Authorization of appropriations To carry out this section, there is authorized to be appropriated $2,000,000 for each of fiscal years 2024 through 2029. .